Adems, hubo un mayor nmero de personas que lograron niveles de normoglucemia con la dosis ms alta de orforglipron que con semaglutida oral (37,1% frente a 12,5%)
December 2nd, 2024: Ozempic lawsuit grows to 1,300 cases with 79 new gastroparesis claims filed The Ozempic and GLP-1 Weight Loss Drugs lawsuit addresses allegations that these medications have caused serious gastrointestinal side effects, such as gastroparesis, nausea, and vomiting
But both are effective, and the best choice depends on your goals, tolerability, and cost
Wegovy maker's board shaken up as directors quit The company behind weight-loss jab Wegovy and diabetes drug Ozempic will have a boardroom clear-out, with seven board members including the chairman set to depart
It appears safe so far, but long-term data is still limited